(Q35072255)

6 August 2017

1 reference

title

The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting (English)

1 reference

6 August 2017

Leonard Mattano

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Pediatric Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

7 Suppl 3

1 reference

6 August 2017

page(s)

71-75

1 reference

The short-term changes of bone mineral metabolism following bone marrow transplantation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Bone mineral density after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Avascular necrosis following bone marrow transplantation: a case-control study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Bone mass after treatment for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Molecular signals in anti-apoptotic survival pathways.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Nontraumatic necrosis of bone (osteonecrosis).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.11.X

7 January 2021

10.1034/J.1399-3046.7.S3.11.X

Identifiers

DOI

1 reference

6 August 2017

1 reference